» Articles » PMID: 23843160

Thyroid MIBG Uptake in Parkinson's Disease with Diabetes Mellitus

Overview
Journal Clin Auton Res
Date 2013 Jul 12
PMID 23843160
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

In our work, we investigated thyroid and cardiac MIBG uptake as potential differential markers. We observed reduced cardiac uptake of MIBG in PD and diabetic CAN, in agreement with the previous studies. However, there was a significant difference between the PD and diabetic cardiac autonomic neuropathy groups with respect to early and delayed thyroid MIBG uptake, in that reduced thyroid MIBG uptake was seen in PD but not in diabetic autonomic neuropathy. We therefore propose that this parameter could be a marker for identifying parkinsonism when it presents together with DM.

Citing Articles

Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson's Disease: A Comprehensive Review.

Rissardo J, Caprara A Brain Sci. 2023; 13(10).

PMID: 37891838 PMC: 10605004. DOI: 10.3390/brainsci13101471.


Thyroid [I]MIBG uptake in Parkinson's disease and diabetes mellitus.

Fedorova T, Knudsen K, Rasmussen T, Horsager J, Nahimi A, Skjaerbaek C IBRO Neurosci Rep. 2023; 14:342-345.

PMID: 37006721 PMC: 10063394. DOI: 10.1016/j.ibneur.2023.03.006.


Systemic Metabolic Alteration Dependent on the Thyroid-Liver Axis in Early PD.

Miyamoto K, Saiki S, Matsumoto H, Suzuki A, Yamashita Y, Iseki T Ann Neurol. 2022; 93(2):303-316.

PMID: 36128871 PMC: 10092289. DOI: 10.1002/ana.26510.


In vivo vesicular acetylcholine transporter density in human peripheral organs: an [F]FEOBV PET/CT study.

Horsager J, Okkels N, Van Den Berge N, Jacobsen J, Schact A, Munk O EJNMMI Res. 2022; 12(1):17.

PMID: 35362761 PMC: 8975951. DOI: 10.1186/s13550-022-00889-9.


Imaging the Autonomic Nervous System in Parkinson's Disease.

Knudsen K, Borghammer P Curr Neurol Neurosci Rep. 2018; 18(11):79.

PMID: 30232650 DOI: 10.1007/s11910-018-0889-4.


References
1.
Matsui H, Udaka F, Oda M, Kubori T, Nishinaka K, Kameyama M . Metaiodobenzylguanidine (MIBG) scintigraphy at various parts of the body in Parkinson's disease and multiple system atrophy. Auton Neurosci. 2005; 119(1):56-60. DOI: 10.1016/j.autneu.2005.03.003. View

2.
Taki J, Nakajima K, Hwang E, Matsunari I, Komai K, Yoshita M . Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. taki@med.kanazawa-u.ac.jp. Eur J Nucl Med. 2000; 27(5):566-73. DOI: 10.1007/s002590050544. View

3.
Rascol O, Schelosky L . 123I-metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorders. Mov Disord. 2009; 24 Suppl 2:S732-41. DOI: 10.1002/mds.22499. View

4.
Hirayama M, Hakusui S, Koike Y, Ito K, Kato T, Ikeda M . A scintigraphical qualitative analysis of peripheral vascular sympathetic function with meta-[123I]iodobenzylguanidine in neurological patients with autonomic failure. J Auton Nerv Syst. 1995; 53(2-3):230-4. DOI: 10.1016/0165-1838(95)00002-f. View

5.
Goldstein D, Holmes C, Dendi R, Bruce S, Li S . Orthostatic hypotension from sympathetic denervation in Parkinson's disease. Neurology. 2002; 58(8):1247-55. DOI: 10.1212/wnl.58.8.1247. View